WishBone Medical named Mark Figgie, MD, as its interim CEO, the orthopedic devicemaker said Dec. 1.
Dr. Figgie, a joint replacement specialist at New York City-based Hospital for Special Surgery, replaces WishBone cofounders Nick Deeter and Mary Wetzel as CEO and president, according to a news release. The cofounders will step into consulting roles for the company.
"Dr. Figgie for his advocacy as a foundational board member, investor, and his 40 years of exemplary experience in orthopedics," WishBone board member Manny Losada said in the release. "However, he also has an incredible business acumen ... Dr. Figgie will work alongside the seasoned executive management team and surgeons to create leading-edge solutions that kids deserve."
WishBone Medical, which focuses on pediatric orthopedics, also recieved funding from LKCM Headwater Investments. The amount wasn't disclosed.